ATE219149T1 - Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa - Google Patents
Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosaInfo
- Publication number
- ATE219149T1 ATE219149T1 AT96908202T AT96908202T ATE219149T1 AT E219149 T1 ATE219149 T1 AT E219149T1 AT 96908202 T AT96908202 T AT 96908202T AT 96908202 T AT96908202 T AT 96908202T AT E219149 T1 ATE219149 T1 AT E219149T1
- Authority
- AT
- Austria
- Prior art keywords
- crohn
- disease
- colitis
- ulcerosal
- determining
- Prior art date
Links
- 208000011231 Crohn disease Diseases 0.000 title abstract 3
- 206010009887 colitis Diseases 0.000 title 1
- 206010009900 Colitis ulcerative Diseases 0.000 abstract 2
- 241000712079 Measles morbillivirus Species 0.000 abstract 2
- 201000006704 Ulcerative Colitis Diseases 0.000 abstract 2
- 238000001514 detection method Methods 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 108020005544 Antisense RNA Proteins 0.000 abstract 1
- 108010067390 Viral Proteins Proteins 0.000 abstract 1
- 230000003321 amplification Effects 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000003184 complementary RNA Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
- Electrotherapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9506298.0A GB9506298D0 (en) | 1995-03-28 | 1995-03-28 | Diagnostic system |
| PCT/GB1996/000706 WO1996030544A1 (en) | 1995-03-28 | 1996-03-22 | Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE219149T1 true ATE219149T1 (de) | 2002-06-15 |
Family
ID=10772018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96908202T ATE219149T1 (de) | 1995-03-28 | 1996-03-22 | Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6309819B1 (de) |
| EP (1) | EP0817864B1 (de) |
| JP (1) | JPH11502707A (de) |
| AT (1) | ATE219149T1 (de) |
| AU (1) | AU701316B2 (de) |
| CA (1) | CA2216807A1 (de) |
| DE (1) | DE69621791D1 (de) |
| GB (2) | GB9506298D0 (de) |
| WO (1) | WO1996030544A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2325856A (en) * | 1997-06-05 | 1998-12-09 | Royal Free Hosp School Med | Pharmaceutical composition for treatment of MMR virus mediated disease comprising a transfer factor obtained from the dialysis of virus-specific lymphocytes |
| GB2347742B (en) * | 1997-06-05 | 2001-11-07 | Royal Free Hosp School Med | Pharmaceutical composition for RBD |
| GB9717972D0 (en) * | 1997-08-22 | 1997-10-29 | Amersham Int Ltd | Labelling composition and method |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4871759A (en) | 1973-06-18 | 1989-10-03 | Mercer James B | Method of treatment of mesenteric adenitis |
-
1995
- 1995-03-28 GB GBGB9506298.0A patent/GB9506298D0/en active Pending
-
1996
- 1996-03-22 EP EP96908202A patent/EP0817864B1/de not_active Expired - Lifetime
- 1996-03-22 AT AT96908202T patent/ATE219149T1/de not_active IP Right Cessation
- 1996-03-22 AU AU51531/96A patent/AU701316B2/en not_active Ceased
- 1996-03-22 DE DE69621791T patent/DE69621791D1/de not_active Expired - Lifetime
- 1996-03-22 WO PCT/GB1996/000706 patent/WO1996030544A1/en not_active Ceased
- 1996-03-22 US US08/913,982 patent/US6309819B1/en not_active Expired - Fee Related
- 1996-03-22 GB GB9606038A patent/GB2300259B/en not_active Expired - Fee Related
- 1996-03-22 CA CA002216807A patent/CA2216807A1/en not_active Abandoned
- 1996-03-22 JP JP8529060A patent/JPH11502707A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11502707A (ja) | 1999-03-09 |
| US6309819B1 (en) | 2001-10-30 |
| GB2300259B (en) | 1999-06-23 |
| AU5153196A (en) | 1996-10-16 |
| WO1996030544A1 (en) | 1996-10-03 |
| HK1002983A1 (en) | 1998-09-30 |
| CA2216807A1 (en) | 1996-10-03 |
| DE69621791D1 (de) | 2002-07-18 |
| GB2300259A (en) | 1996-10-30 |
| AU701316B2 (en) | 1999-01-28 |
| EP0817864A1 (de) | 1998-01-14 |
| GB9506298D0 (en) | 1995-05-17 |
| GB9606038D0 (en) | 1996-05-22 |
| EP0817864B1 (de) | 2002-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Klimstra et al. | The furin protease cleavage recognition sequence of Sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfate | |
| Becker | Cancer a Comprehensive Treatise 2: Etiology: Viral Carcinogenesis | |
| Chou | Differentiation of cytomegalovirus strains by restriction analysis of DNA sequences amplified from clinical specimens | |
| DE69332642D1 (de) | Methoden zur detektion von mikrometastasen bei prostata-krebs | |
| Young et al. | Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells | |
| Dhar et al. | Nucleotide sequence of the DNA replication origin for human papovavirus BKV: sequence and structural homology with SV40 | |
| TR199800613A1 (xx) | Nezle A��s�. | |
| HU9300398D0 (en) | Oligo-nucleotides influencing effect of infection by cyto-megalo virus | |
| ES2013346A6 (es) | Metodos para producir secuencias y moleculas de adn recombinante, asi como proteinas t4 solubles. | |
| ATE419368T1 (de) | System zum transfer und zur expression von heterologen genen ins knochenmark in vivo | |
| ATE121794T1 (de) | Verfahren zum nachweis des karzinogenen menschlichen papillomavirus. | |
| ATE428003T1 (de) | Oligonukleotidprimer zur effizienten detektion von hepatitis c virus (hcv) sowie verwendungsverfahren | |
| Hayashi et al. | Elucidation of a conserved RNA stem-loop structure in the packaging signal of human immunodeficiency virus type 1 | |
| UA48936C2 (uk) | Спосіб одержання вірусу курячої анемії (cav) у дволанцюговій формі, рекомбінантна нуклеїнова кислота (варіанти), діагностичний набір (варіанти), вакцинний препарат (варіанти), культура клітин (варіанти), спосіб одержання діагностичного набору (варіанти) | |
| ZA200102182B (en) | Identification of microorganisms causing acute respiratory tract infections (ARI). | |
| Reis et al. | Recombinant envelope protein (rgp90) ELISA for equine infectious anemia virus provides comparable results to the agar gel immunodiffusion | |
| Tooker et al. | Semliki Forest virus multiplication in clones of Aedes albopictus cells | |
| HUP9901005A2 (hu) | Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B | |
| DE69621791D1 (de) | Verfahren zur bestimmung von crohn's krankheit und colitis ulcerosa | |
| NO20005608L (no) | Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav | |
| Holmes et al. | Coronavirus receptor specificity | |
| WO1996040764A3 (en) | Nucleotide and amino acid sequences of hypervariable region 1 of the envelope 2 gene of hepatitis c virus | |
| Omar et al. | Syncytium Formation and Inhibition in Semliki-Forest-Virus-Infected Aedes Albopictus Cells at Low pH | |
| Zampino et al. | Hepatitis G virus/GBV‐C persistence: absence of hypervariable E2 region and genetic analysis of viral quasispecies in serum and lymphocytes | |
| HUP0200320A2 (hu) | Macskaeredetű CD28-at, CD80-at, CD86-ot vagy CTL4-A-t expresszáló rekombináns vírusok és alkalmazásuk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |